Skip to main content
. 2021 Aug 26;28(5):3297–3315. doi: 10.3390/curroncol28050286

Table 3.

Multivariable logistic regression analyses for end of life (EOL) health service quality indicators with socio-demographics, general health, disease and treatment characteristics of NSCL cancer patients who died from cancer-related causes from January 2009 to December 2017 (N = 37,203).

Characteristics Aggressive Care Supportive Care
Yes No Adjusted Stepwise Model Yes No Adjusted Stepwise Model
N = 18,692 (%) N = 18,499 (%) Odds Ratio (95% CI) N = 20,515 (%) N = 13,507 (%) Odds Ratio (95% CI)
Socio-demographics
Death year *
Mean ± SD 2012.56 ± 2.56 2012.95 ± 2.54 0.96 (0.95–0.97) 2012.97 ± 2.55 2012.53 ± 2.53 1.03 (1.02–1.04)
Age at death date
20–49 523 (2.80) 330 (1.78) Reference 514 (2.51) 274 (2.03)
50–59 2392 (12.80) 1990 (10.76) 0.69 (0.59–0.81) 2695 (13.14) 1382 (10.23)
60–69 5192 (27.78) 4576 (24.74) 0.56 (0.48–0.66) 5656 (27.57) 3366 (24.92)
70–79 6217 (33.26) 6114 (33.05) 0.45 (0.39–0.53) 6797 (33.13) 4408 (32.63)
80+ 4368 (23.37) 5489 (29.67) 0.31 (0.27–0.36) 4853 (23.66) 4077 (30.18)
Sex
Female 8218 (43.97) 9277 (50.15) Reference 9961 (48.55) 6164 (45.64) Reference
Male 10,474 (56.03) 9222 (49.85) 1.21 (1.16–1.26) 10,554 (51.45) 7343 (54.36) 0.95 (0.91–1.00)
Neighborhood income quintile at death date
1 Lowest 4747 (25.40) 4528 (24.48) 4820 (23.50) 3645 (26.99) Reference
2 4227 (22.61) 4079 (22.05) 4583 (22.34) 3007 (22.26) 1.13 (1.06–1.22)
3 3658 (19.57) 3623 (19.58) 4105 (20.01) 2580 (19.10) 1.15 (1.07–1.23)
4 3214 (17.19) 3268 (17.67) 3673 (17.90) 2246 (16.63) 1.19 (1.11–1.29)
5 Highest 2781 (14.88) 2945 (15.92) 3284 (16.01) 1973 (14.61) 1.18 (1.09–1.27)
Place of residence at death date
Erie St. Clair 1012 (5.41) 1316 (7.11) 0.60 (0.53–0.69) 1469 (7.16) 732 (5.42) 2.09 (1.81–2.41)
South West 1660 (8.88) 1360 (7.35) 0.97 (0.86–1.09) 1605 (7.82) 1124 (8.32) 1.41 (1.24–1.61)
Waterloo Wellington 784 (4.19) 1128 (6.10) 0.71 (0.62–0.80) 1372 (6.69) 465 (3.44) 2.86 (2.47–3.32)
Hamilton Niagara Halimand Brant 2105 (11.26) 2797 (15.12) 0.68 (0.61–0.76) 2870 (13.99) 1698 (12.57) 1.92 (1.71–2.15)
Central West 824 (4.41) 532 (2.88) 1.57 (1.36–1.80) 697 (3.40) 492 (3.64) 1.35 (1.15–1.58)
Mississauga Halton 1045 (5.59) 1036 (5.60) 1.15 (1.01–1.29) 1213 (5.91) 675 (5.00) 1.68 (1.46–1.93)
Toronto Central 1210 (6.47) 1337 (7.23) Reference 1251 (6.10) 1040 (7.70) Reference
Central 1591 (8.51) 1660 (8.97) 1.09 (0.98–1.22) 1577 (7.69) 1325 (9.81) 0.87 (0.77–0.98)
Central East 2709 (14.49) 1854 (10.02) 1.46 (1.31–1.62) 2326 (11.34) 1778 (13.16) 1.11 (0.99–1.25)
South East 1143 (6.11) 1075 (5.81) 0.82 (0.72–0.94) 980 (4.78) 1074 (7.95) 0.88 (0.77–1.01)
Champlain 1714 (9.17) 2047 (11.07) 0.70 (0.63–0.78) 2237 (10.90) 1268 (9.39) 1.78 (1.57–2.01)
North Simcoe Muskoka 830 (4.44) 839 (4.54) 0.73 (0.64–0.84) 1036 (5.05) 535 (3.96) 2.13 (1.82–2.48)
North East 1599 (8.55) 1107 (5.98) 1.02 (0.90–1.15) 1539 (7.50) 879 (6.51) 1.99 (1.73–2.28)
North West 466 (2.49) 411 (2.22) 0.91 (0.76–1.08) 343 (1.67) 422 (3.12) 0.66 (0.55–0.80)
Rurality status at death date
Yes 3524 (18.85) 2322 (12.55) 1.09 (1.00–1.20) 3089 (15.06) 2166 (16.04) 0.94 (0.88–1.00)
Type of environment at death date
Urban (RIO < 10) 10,737 (57.44) 12,209 (66.00) 0.59 (0.53–0.66) 12,620 (61.52) 8397 (62.17) 0.82 (0.75–0.89)
Suburban
(10 ≤ RIO < 40)
4990 (26.70) 4536 (24.52) 0.73 (0.66–0.81) 5434 (26.49) 3373 (24.97) 1.00 (0.92–1.10)
Rural (40 ≤ RIO) 2711 (14.50) 1580 (8.54) Reference 2250 (10.97) 1563 (11.57) Reference
General health characteristics
Chronic comorbidities prior to death
Asthma 3283 (17.56) 3156 (17.06) 3464 (16.89) 2399 (17.76)
Chronic
obstructive
pulmonary disease
11,397 (60.97) 10,743 (58.07) 1.05 (1.00–1.10) 11,889 (57.95) 8326 (61.64) 0.96 (0.91–1.01)
Congestive heart
failure
3643 (19.49) 2984 (16.13) 1.12 (1.05–1.19) 3084 (15.03) 2795 (20.69) 0.88 (0.82–0.94)
Elixhauser comorbidity index **
0–1 8389 (44.88) 9982 (53.96) Reference 11,086 (54.04) 6106 (45.21) Reference
2–3 6371 (34.08) 5478 (29.61) 1.46 (1.39–1.54) 6149 (29.97) 4547 (33.66) 0.76 (0.72–0.81)
4+ 3932 (21.04) 3039 (16.43) 1.66 (1.55–1.77) 3280 (15.99) 2854 (21.13) 0.68 (0.64–0.74)
Disease and treatment characteristics
Number of months from first cancer diagnosis to death
0–<1 4100 (21.93) 1592 (8.61) Reference 1233 (6.01) 3618 (26.79) Reference
1–<2 2216 (11.86) 2164 (11.70) 0.41 (0.37–0.45) 1988 (9.69) 1824 (13.50) 2.59 (2.35–2.85)
2–<3 1512 (8.09) 1731 (9.36) 0.39 (0.35–0.42) 1878 (9.15) 1068 (7.91) 3.69 (3.31–4.10)
3–<6 2617 (14.00) 3150 (17.03) 0.38 (0.35–0.42) 3754 (18.30) 1638 (12.13) 4.37 (3.97–4.81)
6–<12 2700 (14.44) 3153 (17.04) 0.39 (0.36–0.43) 3977 (19.39) 1556 (11.52) 4.75 (4.31–5.23)
12+ 5547 (29.68) 6709 (36.27) 0.37 (0.35–0.41) 7685 (37.46) 3803 (28.16) 4.04 (3.71–4.41)
Prior adjuvant systemic therapy for thoracic tumour resection or curative concurrent chemoradiation
Prior to death date 1463 (7.83) 1382 (7.47) 1.18 (1.08–1.28) 1752 (8.54) 905 (6.70) 0.83 (0.76–0.92)
Palliative intent systemic therapy, radiotherapy and metastasis surgery
Prior to death date 8962 (47.95) 10,700 (57.84) 0.87 (0.83–0.92) 13,139 (64.05) 5551 (41.10) 1.49 (1.41–1.57)
Number of days from first access to palliative care consultation *** to death
>180 983 (5.26) 1719 (9.29) 0.56 (0.51–0.62) 2165 (10.55) 467 (3.46) 3.46 (3.09–3.88)
61–180 1334 (7.14) 2665 (14.41) 0.49 (0.46–0.53) 3189 (15.54) 674 (4.99) 3.41 (3.10–3.76)
31–60 1024 (5.48) 1906 (10.30) 0.53 (0.49–0.58) 2121 (10.34) 625 (4.63) 2.75 (2.49–3.04)
≤30 3764 (20.14) 2959 (16.00) 1.06 (0.99–1.12) 3454 (16.84) 2510 (18.58) 1.55 (1.45–1.66)
None 11,587 (61.99) 9250 (50.00) Reference 9586 (46.73) 9231 (68.34) Reference

CI, Confidence Interval; RIO, Rurality Index for Ontario; * Odds ratio measured as per 1-year increase; ** Five-year lookback from death: Total comorbidity score excludes indices for metastatic cancer and solid tumour without metastases; *** OHIP billing codes: A945, C945; Notes: Aggressive and supportive care outcomes were both composite scores for occurrence of any one or more the respective indicators; In the adjusted stepwise model, variables with a significance level of 0.20 were used for model selection and variables with a significance level of 0.10 remained in the final model. The stepwise model selection approach excluded variables that do not significantly contribute to the final model; Missing values for the outcomes and variables were first excluded before running the logistic regression analyses. Significant associations discussed in the text are bolded.